Placement Announced

Chimeric Therapeutics placement (May 2025)

A$6.6m raised

Announced 20 May 2025 · ASX: CHM

Advisers

Chimeric Therapeutics

Issuer

Not disclosed

Lead managers

Joint lead manager
Issuer
Chimeric Therapeutics
Issuer based in
Australia
Sector
Biotech
Tags
Biotech, Cell Therapy, Oncology

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.